Mesa Laboratories Issues Fiscal 2027 Revenue Guidance and Announces $40 Million Share Buyback
Mesa Laboratories (MLAB) has provided its financial outlook for fiscal year 2027, projecting revenues between $250 million and $255 million. The company also expects adjusted EBITDA to fall within the range of $66 million to $68 million. In addition to the revenue guidance, management announced a new $40 million share repurchase program. CEO Siddhartha Kadia provided these projections during the Q2 fiscal 2027 earnings call, signaling confidence in the company's organic growth trajectory and capital allocation strategy.
Tickers: $MLAB
Topics: EBITDA guidance fiscal outlook revenue guidance
Read the full article at Seeking Alpha
Part of the story TransDigm Issues Fiscal 2027 Revenue Guidance and Outlines M&A Strategy (6 articles)